Related Experiment Video
Updated: Jul 19, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and
Asparouh Iliev Iliev1, Sundar Ganesan, Gertrude Bunt
1Cell Biophysics Group, European Neuroscience Institute-Göttingen, Waldweg 33, 37073 Göttingen, Germany. ailiev@gwdg.de
Abstract:
Aggregated and highly phosphorylated tau protein is a pathological hallmark of Alzheimer's disease (AD) and other tauopathies. We identified motifs of alternating polar and apolar amino acids within the microtubule-binding repeats of tau which were interrupted by small breaking stretches. Minimal mutation of these breaking sequences yielded a unique instantly aggregating tau mutant containing longer stretches of polar/apolar amino acids without losing its microtubule-binding capacity. These modifications produced rapid aggregation and cytotoxicity with accompanying occurrence of pathologic tau phosphoepitopes (AT8, AT180, AT270, AT100, Ser(422), and PHF-1) and conformational epitopes (MC-1 and Alz50) in cells. Similar to pathological tau in the pretangle state, toxicity appeared to occur early without the requirement for extensive fibril formation. Thus, our mutant protein provides a novel platform for the investigation of the molecular mechanisms for toxicity and cellular behavior of pathologically aggregated tau proteins and the identification of its interaction partners.
Insights
Researchers created a novel tau protein mutant that rapidly aggregates and causes cell toxicity, mimicking Alzheimer's disease pathology. This offers a new tool to study tauopathies and identify therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Aggregated and phosphorylated tau protein is a key marker in Alzheimer's disease (AD) and tauopathies.
- Understanding tau aggregation mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To engineer a tau mutant that rapidly aggregates and exhibits cytotoxicity.
- To establish a new platform for studying the molecular basis of tau-related neurodegeneration.
Main Methods:
- Identification of specific amino acid motifs within tau's microtubule-binding repeats.
- Minimal mutations were introduced into identified 'breaking sequences' of tau.
- Cellular assays were performed to assess aggregation, cytotoxicity, and phosphoepitope formation.
Main Results:
- A novel tau mutant was generated with enhanced polar/apolar amino acid stretches, leading to rapid aggregation.
- The mutant tau exhibited significant cytotoxicity and formed pathological phosphoepitopes (AT8, AT180, etc.) and conformational epitopes (MC-1, Alz50).
- Toxicity was observed early, independent of extensive fibril formation, similar to pretangle tau pathology.
Conclusions:
- Engineered tau mutants provide a valuable model for investigating the early mechanisms of tau toxicity in neurodegenerative diseases.
- This research facilitates the study of pathologically aggregated tau and the identification of potential therapeutic targets.
More Related Videos
Related Concept Videos
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Instability
Microtubule Instability
Microtubule Associated Proteins (MAPs)
Drugs that Destabilize Microtubules

